Page last updated: 2024-08-23

pravastatin and Left Ventricular Dysfunction

pravastatin has been researched along with Left Ventricular Dysfunction in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's3 (50.00)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ara, N; Iuchi, A; Miyoshi, H; Mizuguchi, Y; Nagase, N; Oishi, Y; Oki, T1
Abouelnaga, ZA; Alhaj, MA; Awad, MM; Citro, LA; El-Sayed, O; Elnakish, MT; Hassanain, HH; Hassona, MD; Khan, M; Kulkarni, A; Kuppusamy, P; Moldovan, L; Sayyid, M1
Can, L; Evrengul, H; Kayikcioglu, M; Kultursay, H; Payzin, S1
Goto, Y; Kanda, M; Kinoshita, H; Miyazaki, S; Nagaya, N; Nonogi, H; Yasuda, S1
Chen, Y; Kohno, M; Kosaka, H; Mizukawa, M; Ohmori, K; Shinomiya, K; Yoshida, J; Zeng, Y; Zhang, L1
Dyer, Z; Gelberg, HJ; Kupperman, JL; Liebhaber, MI; Wright, RS1

Trials

2 trial(s) available for pravastatin and Left Ventricular Dysfunction

ArticleYear
Influence of comorbid cardiovascular risk factors on left atrial-left ventricular interaction in asymptomatic patients: clinical application of two-dimensional speckle-tracking echocardiography.
    International heart journal, 2014, Volume: 55, Issue:2

    Topics: Aged; Atherosclerosis; Atrial Function, Left; Carotid Intima-Media Thickness; Dose-Response Relationship, Drug; Double-Blind Method; Echocardiography; Female; Fluorobenzenes; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pravastatin; Prospective Studies; Pyrimidines; Risk Factors; Rosuvastatin Calcium; Severity of Illness Index; Sulfonamides; Ventricular Dysfunction, Left; Ventricular Function, Left

2014
The effect of statin therapy on ventricular late potentials in acute myocardial infarction.
    International journal of cardiology, 2003, Volume: 90, Issue:1

    Topics: Adult; Aged; Arrhythmias, Cardiac; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography; Female; Fibrinolytic Agents; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Infarction; Pravastatin; Prospective Studies; Time Factors; Ventricular Dysfunction, Left

2003

Other Studies

4 other study(ies) available for pravastatin and Left Ventricular Dysfunction

ArticleYear
Cardiac remodeling caused by transgenic overexpression of a corn Rac gene.
    American journal of physiology. Heart and circulatory physiology, 2011, Volume: 301, Issue:3

    Topics: Aging; Amino Acid Sequence; Analysis of Variance; Animals; Echocardiography; Genotype; Hypertrophy, Left Ventricular; Integrin alpha1; Integrin beta1; Magnetic Resonance Imaging; Male; MAP Kinase Signaling System; Mice; Mice, Transgenic; Molecular Sequence Data; Mutation; Myocardium; Myosin Heavy Chains; Phenotype; Plant Proteins; Pravastatin; Promoter Regions, Genetic; rac1 GTP-Binding Protein; Superoxides; Thyroxine; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling

2011
Enhanced cardiac production of matrix metalloproteinase-2 and -9 and its attenuation associated with pravastatin treatment in patients with acute myocardial infarction.
    Clinical science (London, England : 1979), 2007, Volume: 112, Issue:1

    Topics: Aged; Analysis of Variance; Angina Pectoris; C-Reactive Protein; Case-Control Studies; Cholesterol; Enzyme Activation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Linear Models; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Middle Aged; Myocardial Infarction; Myocardium; Natriuretic Peptide, Brain; Pravastatin; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2; Ventricular Dysfunction, Left; Ventricular Remodeling

2007
Differential impact of atorvastatin vs pravastatin on progressive insulin resistance and left ventricular diastolic dysfunction in a rat model of type II diabetes.
    Circulation journal : official journal of the Japanese Circulation Society, 2007, Volume: 71, Issue:1

    Topics: Adiponectin; Adipose Tissue; Animals; Anticholesteremic Agents; Atorvastatin; Chemokine CCL2; Diabetes Mellitus, Type 2; Disease Models, Animal; Gene Expression Regulation; Glucose; Heptanoic Acids; Hypertriglyceridemia; Insulin Resistance; Leptin; Myocardium; Nitric Oxide; Nitric Oxide Synthase Type III; Pravastatin; Pyrroles; Rats; Rats, Long-Evans; Rats, Mutant Strains; RNA, Messenger; Transforming Growth Factor beta1; Ventricular Dysfunction, Left

2007
Polymyalgia, hypersensitivity pneumonitis and other reactions in patients receiving HMG-CoA reductase inhibitors: a report of ten cases.
    Chest, 1999, Volume: 115, Issue:3

    Topics: Aged; Aged, 80 and over; Alveolitis, Extrinsic Allergic; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Male; Middle Aged; Polymyalgia Rheumatica; Pravastatin; Ventricular Dysfunction, Left

1999